- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03369405
Thyroid Disease and Chronic Periodontitis
Thyroid Insufficiency as a Modifying Factor for Chronic Periodontitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a retrospective, cross-sectional patient records review study. Only records with subjects that were 35 years or older and have been active patients of the School of Dental Medicine, University at Buffalo will be included. Three individual searches with three distinct patient criteria will be conducted to obtain records from subjects in three populations with different degrees of periodontal disease. All subjects that qualify the eligibility criteria will be selected. The IT Department has access to select the subjects according to the eligibility criteria without requiring access to the physical patient record. The three subject groups are:
- Periodontally healthy patients: Patients with a D1110 or D1111 (adult prophylaxis including those with 6 or fewer teeth) treatment code, seen by a 3rd or 4th year pre-doctoral dental student. Excludes all charts that have ever had a U4990 (Perio case) treatment code. Patient is 35 years or older relative to 1/1/2016.
- Patients with a history of advanced periodontal treatment, group 1: All patients treated in the Postgraduate Periodontics department by a periodontics resident between 1/1/2000 - 12/31/2017. Patients presenting for treatment of chronic periodontitis will be included while those patients presenting to the clinic for other reasons, such as crown lengthening procedures, will be labeled as such. All patients selected will be 35 years or older at time of initial exam.
- Patients with history of advanced periodontal treatment, group 2: All patients ever treated in the private faculty practice of one periodontist, that were still active patients during between 1/1/16 - 12/31/16. Only those 35 years and older were included. Patients presenting for treatment of chronic periodontitis will be included while those patients presenting to the clinic for other reasons, such as crown lengthening procedures, will be labeled as such.
All duplicates within a group will be excluded (e.g. patients may have had a D1110 code more than once per year). These 3 subject search criteria should yield a sufficient number of patient records for statistical analysis.
All patient records will be reviewed and data will be collected and recorded in an electronic Microsoft Excel database file that is saved on an encrypted flash drive. The only patient identifier recorded will be the patient records number. Once data collection is complete, or at a maximum of 3 years from the start of the study, all identifying information will be deleted and only de-identified data saved on a separate electronic file will be analyzed. No code key will be required.
Data will be analyzed using ANOVA (F-test). If multiple variables are used, analysis will be by using generalized estimating equations (GEE).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14214
- School of Dental Medicine, University at Buffalo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
The study population is sampled from the patient records available at the School of Dental Medicine, University at Buffalo, State University of New York. The patient records reviewed will be of patients seen in the predoctoral as well as postgraduate clinics.
The third group population is sampled from the patient records available from the faculty practice of one provider located at the University of Buffalo, State University of New York
Description
Inclusion Criteria:
- Active patient of the School of Dental Medicine, University at Buffalo.
The remaining eligibility criteria varies between the three distinct subject populations, which are noted below. All eligibility criteria is selected for by an electronic search of patient records performed by the IT Department at the School of Dental Medicine, University at Buffalo.
Periodontally healthy patients:
- A treatment code of D1110 or D111 was processed at least once but excluding patients that were ever assigned a treatment code of U4990
- A 3rd or 4th year pre-doctoral dental student provider
- 35 years or older as of 1/1/2016
- Patient presented to clinic between 1/1/2016-12/31/2016
Patients with history of advanced periodontal treatment, group 1:
- All patients presenting to the Postgraduate Periodontics Department at UB and being seen by a periodontics resident
- Time period between 1/1/2000-12/31/2017
- Patients will be 35 years or older at time of initial exam
- Patients presenting for reasons other than chronic periodontitis treatment (e.g. crown lengthening) will be labeled as such.
Patients with history of advanced periodontal treatment, group 2:
- All patients treated in the faculty practice of one periodontist that remained active patients during the time period 1/1/2016-12/31-2016
- All patients were 35 years or older at time of initial exam
Duplicates within groups are eliminated.
Exclusion Criteria:
- inadequate data from records
Note: the majority of patient records selected by the search criteria done electronically by the IT department will be included in the study, since the search criteria very closely overlaps the overall study criteria
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Periodontally healthy patients
Patients that have no history of periodontal treatment and that have been scheduled for routine prophylaxis appointments in the predoctoral clinics at the School of Dental Medicine, University at Buffalo.
|
There is no intervention - the three study groups are created by utilizing three unique sets of search criteria for the patient records review.
|
|
Periodontitis, group 1
Patients that have been referred from the pre-doctoral dental clinics to the Postgraduate Periodontics clinic for advanced periodontal disease.
Clinical attachment loss, pain, mobility, bleeding, suppuration, and probing depths > 4 mm more likely to be prevalent.
|
There is no intervention - the three study groups are created by utilizing three unique sets of search criteria for the patient records review.
|
|
Periodontitis, group 2
Patients referred to a faculty practice periodontist over the course of his clinical career due to chronic periodontitis that could not be treated by the referring general dentist.
Clinical attachment loss, pain, mobility, bleeding, suppuration, and probing depths > 4 mm more likely to be prevalent.
|
There is no intervention - the three study groups are created by utilizing three unique sets of search criteria for the patient records review.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Thyroid disease prevalence
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
The presence or absence of thyroid medication in the patient record will be used as a surrogate marker for thyroid disease presence or absence.
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
smoking history
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Smoking history will be determined from the Medical Questionnaire form in the patient records.
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
diabetes disease prevalence
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
The Medical Questionnaire and the Medication List in the patient records will be referenced to determine the presence of diabetes.
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
Periodontal Probing Depths 5mm or greater
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Number of teeth that have one or more sites that contain a 5mm or greater pocket, recorded in periodontal chart
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
Periodontal Probing Depths 6mm or greater
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Number of teeth that have one or more sites that contain a 6mm or greater pocket, recorded in periodontal chart
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
Teeth
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Total number of teeth, recorded in periodontal chart
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
proton pump inhibitor use
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
The Medication List in the patient records will be referenced to determine any history of proton pump inhibitor use.
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
Plaque Score
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Percentage of tooth surfaces positive for plaque out of total tooth surfaces
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
Hormone replacement therapy
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
The presence or absence of hormone supplementation (birth control or hormone replacement therapy included)
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
|
bisphosphonate use
Time Frame: Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
The Medication List in the patient records will be referenced to determine any history of bisphosphonate use.
|
Assessed at one time point only, during patient's initial exam noted in patient records (cross-sectional study).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00001811
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Diseases
-
AllerganCompletedHypothyroidism | Thyroid Disease | Euthyroid | Thyroid Gland | Thyroid HormonesUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); University of MichiganCompletedThyroid Cancer | Thyroid Nodule | Benign Thyroid NoduleUnited States
-
Imperial College LondonActive, not recruitingThyroid Cancer | Nodule Solitary ThyroidUnited Kingdom
-
Aarhus University HospitalOdense University Hospital; University of AarhusActive, not recruitingThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
Second Affiliated Hospital of Nanchang UniversitySun Yat-sen University; Beijing Friendship Hospital; Zhejiang University; General... and other collaboratorsActive, not recruitingThyroid | Thyroid Cancer | Thyroid AbnormalitiesChina
-
Tseung Kwan O Hospital, Hong KongRecruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid NoduleHong Kong
-
Wuhan UniversityRecruitingThyroid Carcinoma | Thyroid Nodule (Benign) | Ablation; RetinaChina
-
Sound Blade Medical Inc.Not yet recruitingThyroid Nodules | Thyroid Abnormalities
-
National Cancer Institute (NCI)TerminatedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Anaplastic Thyroid Cancer | Stage III Follicular Thyroid Cancer | Stage III Papillary Thyroid CancerUnited States
-
University of CagliariProf. Pietro Giorgio Calò; Dott. Gian Luigi CanuNot yet recruitingThyroid Cancer | Thyroid NoduleItaly
Clinical Trials on NO intervention, patient records review only
-
University of PittsburghCompleted
-
University of WashingtonCompletedImplantable Cardioverter Defibrillator (ICD)United States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke... and other collaboratorsCompleted
-
University College CorkCompleted
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Prostate Cancer Foundation of ChicagoCompletedProstate Cancer | Cardiovascular DeathUnited States
-
Xuanwu Hospital, BeijingRecruitingCoexistence of Cerebral and Coronary Atherosclerosis | Acute Ischemic Cerebrovascular DiseaseChina
-
University Medicine GreifswaldRecruitingMetabolic Syndrome | Chronic Heart FailureGermany
-
Xiang XieThe Third Affiliated Hospital of Jinzhou Medical University; Affiliated Traditional...CompletedAcute Coronary SyndromeChina